SLC6A4 and depressive symptom measurement: We wanted to determine whether epigenetic changes, such as DNA methylation patterns of the candidate genes (BDNF, COMT, and SLC6A4) in peripheral blood, correlate with the duration and acute severity of anxiety and depression symptoms measured with clinical scales (BDI-II, HAM-A, and IDS-C).